Investors

Welcome to the Biofarma Group Investor relations area

News

Kepler S.P.A. Financial Results for Q1 2023

Kepler S.P.A. Financial Results for Q1 2023

Leggi
Biofarma signs the acquisition of US Pharma Lab

Biofarma signs the acquisition of US Pharma Lab

Leggi
Kepler S.P.A. Financial Results for FY 2022

Kepler S.P.A. Financial Results for FY 2022

Leggi
Biofarma Group appoints Gianfranco Nazzi as new CEO

Biofarma Group appoints Gianfranco Nazzi as new CEO

Leggi
General Manager Exit

General Manager Exit

Leggi
Kepler S.P.A. Financial Results for Q3 2022

Kepler S.P.A. Financial Results for Q3 2022

Leggi
Biofarma Group financial calendar

Biofarma Group financial calendar

Leggi
Kepler S.P.A. Financial Results for H1 2022

Kepler S.P.A. Financial Results for H1 2022

Leggi
Kepler S.P.A. Financial Results for Q1 2022

Kepler S.P.A. Financial Results for Q1 2022

Leggi
Kepler S.P.A. announces the closing of the offering of its €345.0 million senior secured floating rate notes due 2029

Kepler S.P.A. announces the closing of the offering of its €345.0 million senior secured floating rate notes due 2029

Leggi